Abdominal Aortic Aneurysm CTA Cohort Study (AAA-CTA Registry)

What this Trial Is About

Abdominal aortic aneurysm (AAA) is a serious vascular condition involving the enlargement of the abdominal aorta, which can lead to rupture and life-threatening bleeding. Because AAA often shows no symptoms until rupture, early detection and accurate monitoring are essential. This research focuses on evaluating computed tomography angiography (CTA) as a key imaging method to improve diagnosis and risk assessment for AAA. The study collects CTA imaging results from patients with AAA seen in inpatient, emergency, and outpatient settings at the study hospital. CTA provides detailed images of the aneurysm's size, wall thickness, thrombus presence, and relation to nearby structures. These details are important for making decisions about when to intervene and how to manage the condition. Participants will have their maximal abdominal aortic diameter measured using CTA within one month, along with tracking of rupture events, mortality, and other aneurysm characteristics. The study gathers important clinical data to help refine AAA screening and treatment timing. Participation involves undergoing CTA scans and data collection, with the aim to develop better assessment standards and personalized care for AAA patients.

AAA-CTA Cohort Registry